[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study will use PET scans, which is a type of x-ray test that uses a radiotracer, to see
whether these scans may be better able to find places in the body where your prostate cancer
may have spread.